Cargando…

Non-Redundant and Overlapping Oncogenic Readouts of Non-Canonical and Novel Colorectal Cancer KRAS and NRAS Mutants

RAS oncogene family members are molecular switches of signaling pathways that control cell growth, proliferation, differentiation, and survival. In colorectal cancer, Kirsten-RAS (KRAS) and neuroblastoma-RAS (NRAS) are the commonly mutated isoforms. Activating mutations in RAS result in cellular tra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alcantara, Krizelle Mae M., Malapit, Joshua Reginald P., Yu, Ryan Timothy D., Garrido, Jose Antonio Ma. G., Rigor, John Paul T., Angeles, Arlou Kristina J., Cutiongco-de la Paz, Eva Maria, Garcia, Reynaldo L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6952822/ https://www.ncbi.nlm.nih.gov/pubmed/31816869 http://dx.doi.org/10.3390/cells8121557

Ejemplares similares

Phenotypic characterization of the novel, non-hotspot oncogenic KRAS mutants E31D and E63K
por: Angeles, Arlou Kristina J., et al.
Publicado: (2019)

MicroRNA-92a promotes cell proliferation, migration and survival by directly targeting the tumor suppressor gene NF2 in colorectal and lung cancer cells
por: Alcantara, Krizelle Mae M., et al.
Publicado: (2019)

The Novel Phosphatase Domain Mutations Q171R and Y65S Switch PTEN from Tumor Suppressor to Oncogene
por: Garrido, Jose Antonio Ma. G., et al.
Publicado: (2021)

Identification and validation of mRNA 3′untranslated regions of DNMT3B and TET3 as novel competing endogenous RNAs of the tumor suppressor PTEN
por: Roquid, Kenneth Anthony R., et al.
Publicado: (2019)

NRAS and KRAS polymorphisms are not associated with hepatoblastoma susceptibility in Chinese children
por: Yang, Tianyou, et al.
Publicado: (2019)

The predictive value of KRAS and NRAS mutations in metastatic colorectal cancer
por: Eshraghi, Abbas, et al.
Publicado: (2020)

KRAS/NRAS/BRAF Mutations as Potential Targets in Multiple Myeloma
por: Pasca, Sergiu, et al.
Publicado: (2019)

NRAS mutant E132K identified in young-onset sporadic colorectal cancer and the canonical mutants G12D and Q61K affect distinct oncogenic phenotypes
por: Yu, Ryan Timothy D., et al.
Publicado: (2020)

KRAS and NRAS pyrosequencing screening in Tunisian colorectal cancer patients in 2015
por: Jouini, Raja, et al.
Publicado: (2019)

Canonical and non-canonical JAK/STAT transcriptional targets may be involved in distinct and overlapping cellular processes
por: Tsurumi, Amy, et al.
Publicado: (2017)

KRAS and NRAS mutational gene profile of metastatic colorectal cancer patients in Jordan
por: Awidi, Muhammad, et al.
Publicado: (2019)

Molecular Pattern and Clinical Implications of KRAS/NRAS and BRAF Mutations in Colorectal Cancer
por: Gökmen, İvo, et al.
Publicado: (2023)

Mutations of KRAS/NRAS/BRAF predict cetuximab resistance in metastatic colorectal cancer patients
por: Hsu, Hung-Chih, et al.
Publicado: (2016)

KRAS, NRAS, and BRAF mutations in plasma cell myeloma at a single Korean institute
por: Kim, Yonggoo, et al.
Publicado: (2020)

Clinicopathological characteristics and mutational profile of KRAS and NRAS in Tunisian patients with sporadic colorectal cancer
por: OUNISSI, Donia, et al.
Publicado: (2021)

KRAS/NRAS/BRAF Mutation Rate in Saudi Academic Hospital Patients With Colorectal Cancer
por: Saharti, Samah
Publicado: (2022)

High prevalence of unusual KRAS, NRAS, and BRAF mutations in POLE ‐ hypermutated colorectal cancers
por: Favre, Loetitia, et al.
Publicado: (2022)

KRAS and NRAS Translation Is Increased upon MEK Inhibitors-Induced Processing Bodies Dissolution
por: Vidal-Cruchez, Olivia, et al.
Publicado: (2023)

KRAS, NRAS, BRAF signatures, and MMR status in colorectal cancer patients in North China
por: Lian, Shen-Yi, et al.
Publicado: (2023)

CircPVT1 attenuates negative regulation of NRAS by let-7 and drives cancer cells towards oncogenicity
por: Danac, Joshua Miguel C., et al.
Publicado: (2021)

KRAS, NRAS and BRAF mutations in Greek and Romanian patients with colorectal cancer: a cohort study
por: Negru, Serban, et al.
Publicado: (2014)

Mutation Status and Immunohistochemical Correlation of KRAS, NRAS, and BRAF in 260 Chinese Colorectal and Gastric Cancers
por: Yang, Qiwei, et al.
Publicado: (2018)

Diferencias Clínicas de las mutaciones KRAS y NRAS en pacientes con cáncer colorrectal : /
por: Gudiño Cobos, Luis Omar
Publicado: (2015)

Detection of KRAS, NRAS and BRAF by mass spectrometry - a sensitive, reliable, fast and cost-effective technique
por: Kriegsmann, Mark, et al.
Publicado: (2015)

FOLFIRI plus panitumumab in the treatment of wild-type KRAS and wild-type NRAS metastatic colorectal cancer
por: Geredeli, Caglayan, et al.
Publicado: (2018)

KRAS, NRAS, BRAF, HER2 and Microsatellite Instability in Metastatic Colorectal Cancer – Practical Implications for the Clinician
por: Afrăsânie, Vlad-Adrian, et al.
Publicado: (2019)

Atypical CML with TET2 mutation, associated with NRAS and KRAS: A case report and literature review
por: Abuzneid, Yousef S., et al.
Publicado: (2021)

Correlation between KRAS, NRAS and BRAF mutations and tumor localizations in patients with primary and metastatic colorectal cancer
por: Bożyk, Aleksandra, et al.
Publicado: (2021)

KRAS, NRAS, BRAF, HER2 and MSI Status in a Large Consecutive Series of Colorectal Carcinomas
por: Martianov, Aleksandr S., et al.
Publicado: (2023)

Non-canonical behaviour in canonical theories
por: Jackiw, R
Publicado: (1969)

Canonical and Non-canonical Reelin Signaling
por: Bock, Hans H., et al.
Publicado: (2016)

Circular RNAs: Non-Canonical Observations on Non-Canonical RNAs
por: Stringer, Brett W., et al.
Publicado: (2023)

Clinicopathological features and prognostic roles of KRAS, BRAF, PIK3CA and NRAS mutations in advanced gastric cancer
por: Takahashi, Naoki, et al.
Publicado: (2014)

Mutations of KRAS, NRAS, BRAF, EGFR, and PIK3CA genes in urachal carcinoma: Occurence and prognostic significance
por: Módos, Orsolya, et al.
Publicado: (2016)

Frequency of NRAS Gene Mutation in Wild Type KRAS and BRAF Colorectal Cancers; a Single Center Study
por: Momenzadeh, Hooria, et al.
Publicado: (2018)

Association of KRAS and NRAS gene polymorphisms with Wilms tumor risk: a four-center case-control study
por: Fu, Wen, et al.
Publicado: (2019)

Evaluation of KRAS, NRAS and BRAF mutations detection in plasma using an automated system for patients with metastatic colorectal cancer
por: Franczak, Claire, et al.
Publicado: (2020)

Mutation status and prognostic value of KRAS and NRAS mutations in Moroccan colon cancer patients: A first report
por: El agy, Fatima, et al.
Publicado: (2021)

Sibling rivalry: related bacterial small RNAs and their redundant and non-redundant roles
por: Caswell, Clayton C., et al.
Publicado: (2014)

Redundant and Non-redundant Functions of the AHK Cytokinin Receptors During Gynoecium Development
por: Cerbantez-Bueno, Vincent E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_14ht9v5l6verlmhv094d6l7tc5